Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Aytu Biopharma (AYTU) over the last 8 years, with Q4 2025 value amounting to 0.29%.

  • Aytu Biopharma's Return on Invested Capital rose 400.0% to 0.29% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.29%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.28% for FY2025, which is 2100.0% down from last year.
  • Per Aytu Biopharma's latest filing, its Return on Invested Capital stood at 0.29% for Q4 2025, which was up 400.0% from 0.26% recorded in Q3 2025.
  • Aytu Biopharma's Return on Invested Capital's 5-year high stood at 0.02% during Q1 2024, with a 5-year trough of 1.6% in Q2 2022.
  • Its 5-year average for Return on Invested Capital is 0.48%, with a median of 0.31% in 2024.
  • As far as peak fluctuations go, Aytu Biopharma's Return on Invested Capital plummeted by -5600bps in 2022, and later soared by 12500bps in 2023.
  • Aytu Biopharma's Return on Invested Capital (Quarter) stood at 0.71% in 2021, then tumbled by -79bps to 1.27% in 2022, then surged by 87bps to 0.16% in 2023, then tumbled by -107bps to 0.33% in 2024, then rose by 12bps to 0.29% in 2025.
  • Its last three reported values are 0.29% in Q4 2025, 0.26% for Q3 2025, and 0.22% during Q2 2025.